Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H17NO9S2 |
| Molecular Weight | 491.491 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C2NC(=O)C(C2=CC=C1)(C3=CC=C(OS(O)(=O)=O)C=C3)C4=CC=C(OS(O)(=O)=O)C=C4
InChI
InChIKey=URNFTLVCQLRCMN-UHFFFAOYSA-N
InChI=1S/C21H17NO9S2/c1-13-3-2-4-18-19(13)22-20(23)21(18,14-5-9-16(10-6-14)30-32(24,25)26)15-7-11-17(12-8-15)31-33(27,28)29/h2-12H,1H3,(H,22,23)(H,24,25,26)(H,27,28,29)
Sulisatin (also known as DAN-603) is an indolinone derivative patented by Andreu, Dr., S. A. as a laxative. In preclinical models, Sulisatin increases selectively the colon motility without modifying the speed of gastric, intestinal (small intestine) and caecal emptying in rats. Sulisatin is unable to inhibit water absorption in rat colon while small amounts of Sulisatin may inhibit it significantly.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/583222
rat 1.5, 3 and 6 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29697
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3885
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
C012120
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
5EOG8KQT0Y
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
SUB10745MIG
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
2535
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
C74275
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
m947
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
54935-03-4
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
100000083768
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
41238
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
DTXSID80203451
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104944
Created by
admin on Mon Mar 31 18:45:11 GMT 2025 , Edited by admin on Mon Mar 31 18:45:11 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)